# GLYCYX MOR, INC.: $1,047,803 NIH award, lab equipment and supplies need

**Procurement Fit Score:** 62/100

| Field | Value |
|---|---|
| Organization | GLYCYX MOR, INC. |
| Location | SAN FRANCISCO, CA |
| Funder | NIH |
| Award | $1,047,803 |
| Award date | 2026-09-14 |
| Project | A Phase 2 Trial of Axelopran Plus Pembrolizumab for the First-Line Treatment of Recurrent/Metastatic HNSCC That Is PD-L1 Positive (PD-L1CPS >1) |
| Vendor need | Lab equipment and supplies |
| Original award record | /report/nihbiotechgrantpulse/nih-11418514 |

## Why this score
- Award of $1M+.
- Awarded in the last 90 days.

Source: NIH, NSF, FEMA, EPA, NTIA and DOE awards (via our grant feeds), mapped to vendor procurement needs (https://reporter.nih.gov/project-details/11418514). Last refreshed: 2026-11-04T09:17:22.266Z.
Built from public award data (NIH RePORTER, NSF, OpenFEMA, USASpending.gov), which can lag by weeks. The vendor-need mapping is our classification, not a statement by the grantee; grantees must follow federal procurement rules (2 CFR 200). Not a consumer report and may not be used for FCRA purposes. Informational only; not legal, investment or procurement advice. Not affiliated with any agency or company listed.